Aspira Women's Health Inc.
AWHL- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000926617
No open-market purchases or sales by Aspira Women's Health Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Holders of 5% or more of AWHL
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Aspira Women's Health Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Schuler Jack W | 13D/A | 8.70%4.05M shares | −0.40 ppfrom 9.10% | Mar 10, 20253 filings | Jun 11, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
4 Schedule 13D and 13G filings on Aspira Women's Health Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Jun 11, 20264:05 PM ET | Schuler Jack Wand 1 other | 13D/A | 8.70%4.05M shares | −0.40 ppfrom 9.10% | Jun 5, 2026 | SEC |
| Sep 19, 20255:13 PM ET | Schuler Jack Wand 1 other | 13D/A | 9.10%3.83M shares | −5.60 ppfrom 14.70% | Sep 17, 2025 | SEC |
| Mar 10, 20255:05 PM ET | Schuler Jack Wand 1 other | 13D/A | 14.70%2.72M shares | – | Mar 6, 2025 | SEC |
| Feb 14, 20255:08 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%800.8K shares | –Below 5% | Dec 31, 2024 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Aspira Women's Health Inc. shares.
No Form 144 notices for Aspira Women's Health Inc. are on file.